Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients. [electronic resource]
Producer: 20170928Description: 259-264 p. digitalISSN:- 1557-8615
- APACHE
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Aspergillus
- Autoimmune Diseases -- drug therapy
- Biomarkers
- Bronchoalveolar Lavage Fluid -- chemistry
- Critical Illness
- Early Diagnosis
- Female
- Galactose -- analogs & derivatives
- Graft Rejection -- prevention & control
- Humans
- Immunocompromised Host
- Immunosuppressive Agents -- adverse effects
- Intensive Care Units
- Invasive Pulmonary Aspergillosis -- complications
- Length of Stay
- Male
- Mannans -- metabolism
- Middle Aged
- Mortality
- Neoplasms -- drug therapy
- Neutropenia -- complications
- Organ Dysfunction Scores
- Organ Transplantation
- Respiration, Artificial
- Respiratory Insufficiency -- diagnosis
- Retrospective Studies
- Sensitivity and Specificity
- Young Adult
- beta-Glucans -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.